APA (7th ed.) Citation

Stafylas, P., Farmakis, D., Kourlaba, G., Giamouzis, G., Chatzikou, M., Kossiva, E., . . . Parissis, J. (2016). PCV102 - Cost-Utility Analysis of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure in Greece. Value in Health, 19(7), A654. https://doi.org/10.1016/j.jval.2016.09.1770

Chicago Style (17th ed.) Citation

Stafylas, P., D. Farmakis, G. Kourlaba, G. Giamouzis, M. Chatzikou, E. Kossiva, N. Maniadakis, and J. Parissis. "PCV102 - Cost-Utility Analysis of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure in Greece." Value in Health 19, no. 7 (2016): A654. https://doi.org/10.1016/j.jval.2016.09.1770.

MLA (9th ed.) Citation

Stafylas, P., et al. "PCV102 - Cost-Utility Analysis of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure in Greece." Value in Health, vol. 19, no. 7, 2016, p. A654, https://doi.org/10.1016/j.jval.2016.09.1770.